doxorubicin,sotigalimab
apexigen
['sarcoma', 'award']
and that s a wrap on my last as a fellow! check out our #cd40agonist study in advanced #sarcoma with an exciting signal in #ddlps (mpfs 10.9mo vs. 4mo historical) grateful to and for a #meritaward! #asco2023 
Hematology/Oncology Fellow @ColumbiaCancer
📚 @ColumbiaMedRes ‘20, @HopkinsMedicine ‘17, and @JohnsHopkins ‘12 alum
Budding #sarcoma oncologist